fluorodeoxyglucose f18 has been researched along with Lung Adenocarcinoma in 159 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 92 (57.86) | 24.3611 |
2020's | 67 (42.14) | 2.80 |
Authors | Studies |
---|---|
Lin, J | 1 |
Dong, A; Wang, Y; Zhang, J | 1 |
Ampollini, L; Arena, V; Bertoglio, P; Casadio, C; Filosso, PL; Guerrera, F; Lesca, A; Lococo, F; Lyberis, P; Marchese, V; Paci, M; Puma, F; Rena, O; Ruffini, E; Vannucci, J; Ventura, L; Viti, A | 1 |
Fu, P; Su, YX; Zhang, LH; Zhao, HY | 1 |
Chan, SC; Chang, BS; Chen, YC; Chen, YH; Chu, SC; Li, MH; Lin, CB; Liu, SH; Lue, KH; Wang, LY | 1 |
Bai, Y; Fang, T; Feng, P; Fu, F; Han, H; Huang, Z; Li, D; Li, X; Meng, N; Wang, M; Wang, Z; Wei, W; Yang, Y; Yuan, J | 1 |
Nogami, M | 1 |
Alhun, U; Bandyopadhyay, S; Marchbank, N; Modi, S; Patel, A; Pencharz, D; Wagner, T | 1 |
Bu, L; Feng, H; Han, X; Lin, H; Tu, N; Wang, K; Xie, X; Zhou, Y | 1 |
Aokage, K; Ishii, G; Kojima, M; Miyazaki, S; Miyoshi, T; Nakai, T; Nishina, Y; Nomura, K; Sakamoto, N; Sakashita, S; Samejima, J; Suzuki, K; Taki, T; Tane, K; Tsuboi, M; Watanabe, R | 1 |
Asairinachan, A; Prasad, J; Soputro, NA | 1 |
Chang, C; Chen, T; Lei, B; Liu, L; Ruan, M; Sun, X; Wang, L; Xie, C; Xie, W; Yan, H; Zhang, Q | 1 |
Iguchi, M; Iwasa, H; Matsumoto, T; Miyatake, K; Nakaji, K; Nishimori, M; Nitta, N; Tamura, M; Yamagami, T; Yamanishi, T; Yoshimatsu, R | 1 |
Ecsedi, B; Grahovac, M; Hacker, M; Haug, A; Jiang, C; Kluge, K; Krajnc, D; Li, X; Papp, L; Spielvogel, CP; Wang, S; Yang, S; Zhang, W; Zhao, M | 1 |
Baba, S; Haratake, N; Hashinokuchi, A; Ishigami, K; Kohno, M; Kosai, K; Matsudo, K; Nagano, T; Oku, Y; Ono, Y; Takamori, S; Takenaka, T; Watanabe, K; Yoshizumi, T | 1 |
Du, X; Yu, C; Zhu, F | 1 |
Li, S; Li, Y; Wang, P; Xin, J; Zhao, M | 1 |
Fei, W; Kong, H; Li, N; Meng, X; Yan, S; Yao, Y; Zhang, A; Zhang, Y; Zhou, N; Zhou, X | 1 |
Iijima, Y; Ishikawa, M; Iwai, S; Mizoguchi, T; Motono, N; Uramoto, H | 2 |
Liu, X; Lv, W; Ni, M; Shi, Q; Wang, S; Xie, Q; Zhang, Y; Zhu, X | 1 |
Abbasguliyev, H; Karaman, A | 1 |
Ganesan, P; Goyal, H; Halanaik, D; Kishore, S | 1 |
Gavane, S; Hasanovic, A; Trak, J | 1 |
Chang, BS; Chen, YC; Chen, YH; Chu, SC; Li, MH; Lin, CB; Lue, KH; Wang, LY | 1 |
Chen, Z; Jiang, L; Pan, X; Sun, X; Tan, X; Zeng, B | 1 |
Hou, G; Peng, P; Zhao, Y; Zheng, R | 1 |
Dong, A; Guo, J; Liao, Z | 1 |
Hayashi, N; Iwasa, H; Kato, M; Matsumoto, T; Miyatake, K; Nakaji, K; Nishimori, M; Nitta, N; Tamura, M; Toi, M; Yamagami, T; Yamanishi, T; Yoshimatsu, R | 1 |
Agüloğlu, N; Aksu, A; Unat, DS | 1 |
Abuali, T; Amini, A; Du, D; Glaser, S; Ladbury, C; Liu, A; Liu, J; Massarelli, E; Salgia, R; Villaflor, V; Watkins, W; Williams, T | 1 |
Huang, W; Li, L; Su, Y; Wang, J; Zhou, H | 1 |
Guo, H; Han, L; Lin, L; Liu, Z; Long, F; Zhang, T | 1 |
Li, LJ; Xuan, JZ; Zheng, HN | 1 |
Fan, L; Liu, S; Lyu, D; Tu, W; Wang, Y; Zhou, T | 1 |
Fan, Y; Guo, C; Huang, W; Li, S; Liao, X; Liu, J; Liu, M; Wang, R; Xiong, Y; Zhang, J | 1 |
Fang, N; Jiang, YM; Lin, S; Wang, YL; Xu, AD; Zhang, J | 1 |
Chen, X; Li, P; Wang, D; Wang, X; Zhang, M | 1 |
Ishimura, M; Kanaji, N; Manabe, Y; Mitamura, K; Murao, M; Murota, M; Nishiyama, Y; Norikane, T; Yamamoto, Y | 1 |
Guo, H; Han, L; Han, T; Lin, L; Liu, Z; Long, F; Zhang, T | 1 |
Shen, G; Su, H; Tian, R; Yang, L | 1 |
Gao, Y; Liu, XS; Liu, ZY; Ming, X; Pei, ZJ; Yang, Y; Yuan, LL; Zhang, Y; Zhang, YH | 1 |
Chang, BS; Chen, YC; Chen, YH; Chu, SC; Lin, CB; Lin, HH; Liu, SH; Lue, KH | 1 |
Wang, T; Yang, M; Zhang, J; Zhou, L | 1 |
Aokage, K; Ichikawa, T; Ishii, G; Makinoshima, H; Miyoshi, T; Suzuki, K; Tane, K; Tsuboi, M | 1 |
Inoue, H; Iwama, E; Nakanishi, Y; Okamoto, I; Ota, K; Otsubo, K; Tanaka, K; Tsutsumi, H; Yoneshima, Y | 1 |
Mountz, JM; Muthukrishnan, A; Nguyen, NC | 1 |
Choi, WH; Kang, JH; Kim, YS; Lee, HY; Park, JK; Sung, SW; Yoo, IR | 1 |
Cheng, D; Fu, Z; Hu, B; Shi, H; Xiao, J; Xiu, Y | 1 |
Chang, C; Chen, TX; Lei, B; Liu, L; Ruan, MM; Sun, XY; Teng, HH; Wang, LH; Xie, C; Xie, WH; Yang, YH | 1 |
Bando, Y; Kawakami, Y; Kawakita, N; Kondo, K; Matsumoto, D; Otuska, H; Takashima, M; Takizawa, H; Tangoku, A; Toba, H; Tsuboi, M; Yoshida, M | 1 |
Dai, D; Li, X; Liu, J; Song, X; Sun, Y; Wang, J; Xu, W; Yu, X; Zhang, Y; Zhu, L; Zhu, Y | 1 |
Elboga, U; Yesil Cinkir, H | 1 |
Abel, ED; Ancey, PB; Berezowska, S; Clerc-Rosset, S; Contat, C; Escrig, S; Goepfert, C; Gruetter, R; Jensen, L; Knott, GW; Lanz, B; Lepore, M; Meibom, A; Meylan, E; Neppl, C; Pascual, J; Rathmell, JC; Rossier, A; Sabatino, S; Zangger, N; Zlobec, I | 1 |
Dai, M; Han, J; Hu, Y; Zhang, J; Zhao, X | 1 |
Handa, Y; Ito, H; Mimae, T; Miyata, Y; Nakayama, H; Okada, M; Tsutani, Y | 1 |
Iagaru, A; Ikeda, D; Kozlov, A; Pantel, A | 1 |
Chen, X; Cui, Y; Di, L; Liao, X; Liu, M; Tong, Z; Wang, R | 1 |
Alan, O; Arıkan, R; Babacan, NA; Bozkurtlar, E; Dane, F; Demircan, NC; Ercelep, O; Kaya, S; Lacin, T; Ones, T; Simsek, ET; Telli, TA; Tuylu, TB; Yumuk, PF | 1 |
Cheon, GJ; Choi, H; Ha, S; Heo, DS; Kang, CH; Kang, KW; Keam, B; Kim, DW; Kim, M; Kim, TM; Kim, YT; Na, KJ; Ock, CY; Paeng, JC; Park, C; Park, IK; Park, S | 1 |
Handa, Y; Kagimoto, A; Mimae, T; Miyata, Y; Okada, M; Tsutani, Y | 1 |
Sharma, P | 1 |
Cheng, J; Qi, M; Ren, C; Song, S; Sun, Y; Zhang, J; Zhang, Y | 1 |
Kita, Y; Okamoto, T; Tokunaga, Y | 1 |
Chan, SC; Chen, YH; Chu, SC; Lin, CB; Liu, SH; Lue, KH; Wang, LY; Wang, TF | 1 |
Akagi, M; Hashimoto, K; Nishimura, S | 1 |
Bulutay, P; Cesur, E; Dilege, Ş; Erus, S; Falay, O; Firat, P; Kapdağli, M; Mandel, NM; Selçukbiricik, F; Tanju, S; Yavuz, Ö | 1 |
Aprile, V; Bacchin, D; Bellafiore, S; Bertoglio, P; Carbognani, P; Cattoni, MA; Femia, F; Franzi, F; Gnetti, L; Guerrera, F; Imperatori, AS; Kestenholz, P; Lococo, F; Lucchi, M; Margaritora, S; Minervini, F; Nachira, D; Paci, M; Querzoli, G; Rindi, G; Rodriguez Perez, M; Ruffini, E; Terzi, AC; Ventura, L; Viti, A | 1 |
Akeboshi, M; Fukui, M; Hayashizaki, Y; Imashimizu, K; Itoh, M; Kawaji, H; Ko, W; Mogushi, K; Oh, S; Suzuki, K; Takamochi, K | 1 |
Hu, Y; Li, Y; Liu, G; Shi, H; Tan, H; Xiao, J; Zhang, Y; Zhou, J | 1 |
Cherian, SV; Estrada-Y-Martin, RM; Irani, AD; Weissferdt, A; Zhou, J | 1 |
Abe, H; Ahn, JM; Chen, M; Choe, JH; Choi, H; Endo, H; Goodwin, J; Helke, KL; Inoue, M; Jenkins, DMR; Jeong, JY; Kim, JW; Lee, SY; Minna, JD; Neugent, ML; Robinson, MW; Ruthenborg, RJ; Shackelford, DB; Singh, PK; Takeda, N; Wake, M; Xuan, Z; Yoo, H | 1 |
Gorospe, L; Muñoz-Molina, GM; Pacios-Blanco, RE; Rioja-Martín, ME; Santos-Carreño, AL | 1 |
Castanheira, JC; Costa, DC; Oliveira, C; Silva, ÂF; Vaz, SC | 1 |
Li, ZG | 1 |
Dwary, AD; Khan, EM; Sharma, P | 1 |
Aniskhin, M; Berezina, N; Cherkashin, M; Puchkov, D | 1 |
Miyoshi, Y; Satoh, H; Takayashiki, N | 1 |
Cho, S; Jheon, S; Kim, K; Son, BY; Yum, SW | 1 |
Gormsen, LC; Jochumsen, MR; Nielsen, GL | 1 |
Eshghi, N; Kuo, PH; Lundeen, TF | 1 |
Liu, Y; Wang, XY; Wu, N; Yang, YK; Zhao, YF; Zhu, Z | 1 |
Hatanaka, K; Iwazaki, M; Miyaoka, M; Nakamura, N | 1 |
Cheon, GJ; Chung, JK; Kang, KW; Kim, YI; Lee, DS; Paeng, JC; Park, YS | 1 |
Doai, M; Funasaki, A; Matoba, M; Motono, N; Sekimura, A; Ueda, Y; Uramoto, H; Usuda, K; Yamada, S | 1 |
Chung, JH; Kim, S; Lee, SH; Pahk, K | 1 |
Ayers, K; Bakr, S; Bouchard, G; Diehn, M; Gentles, AJ; Jamali, M; Nair, V; Napel, S; Plevritis, SK; Quon, A; Shafiq, M; Shrager, JB; van de Rijn, M; West, RB; Yu, A; Zhang, W | 1 |
Bian, Y; Hu, Y; Tian, C; Wei, Q; Wu, D | 1 |
Miura, K; Sakamoto, T | 1 |
Cha, SI; Hahm, MH; Jeong, JY; Kim, CH; Lee, H; Lee, HJ; Lee, J; Lim, JK; Park, TI; Shin, KM | 1 |
Asao, T; Atsumi, J; Higuchi, T; Kaira, K; Kitahara, S; Kosaka, T; Mogi, A; Ohtaki, Y; Oyama, T; Shimizu, K; Yajima, T | 1 |
Egashira, R; Hirakawa, H; Kai, K; Kimura, S; Komiya, K; Nakamura, T; Ogusu, S; Sueoka-Aragane, N; Takahashi, K; Takeda, Y; Tanaka, M | 1 |
Li, TC; Lin, J; Ouyang, ML; Tang, K; Xu, MM; Zheng, XW | 1 |
Koh, YW; Lee, SJ; Park, SY | 2 |
Kan, Y; Liu, J; Wang, W; Yang, J; Yang, X | 1 |
Colinas, D; Fra, J; García-Talavera, P; Montes, A; Tamayo, P | 1 |
Koh, YW; Lee, D; Lee, SJ | 1 |
Cheng, Z; Song, S; Zhu, X; Zou, S | 1 |
Chang, YH; Ho, KW; Hsu, CC; Huang, YC | 1 |
Fangliang, L; Miao, H; Nan, L; Shanyuan, Z; Shaolei, L; Yue, Y; Yumei, L | 1 |
Chen, S; Diao, Y; Du, B; Li, X; Li, Y; Sun, T | 1 |
Liu, Y; Lyu, L; Tao, XL; Wang, XY; Wu, N; Yang, L; Zhang, ZK | 1 |
Das, JP; Do, RK; Halpenny, D; Ulaner, GA | 1 |
Miyata, Y; Okada, M; Tsutani, Y | 1 |
Adachi, S; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Tsutani, Y; Yoshimura, M | 3 |
Gotoh, M; Hasegawa, T; Higuchi, M; Osugi, J; Suzuki, H | 1 |
Bongiovanni, M; Ceriani, L; Giovanella, L; Paone, G; Treglia, G | 1 |
Domen, H; Hatanaka, KC; Hatanaka, Y; Hida, Y; Hirano, S; Kaga, K; Matsuno, Y; Okamoto, S; Tamaki, N | 1 |
Bhethanabhotla, S; Durgapal, P; Gajendra, S; Gogia, A; Gupta, R; Sahoo, MK; Tanwar, P | 1 |
Awasthi, V; Sahoo, K; Yadav, VR | 1 |
Endo, M; Kaira, K; Kenmotsu, H; Murakami, H; Naito, T; Nakajima, T; Ohde, Y; Ono, A; Takahashi, T; Yamamoto, N | 1 |
Chung, HW; Kim, HJ; Kim, WS; Lee, KY; So, Y | 1 |
Fukui, M; Hattori, A; Matsunaga, T; Oh, S; Suzuki, K; Takamochi, K; Tsushima, Y | 1 |
Hirami, Y; Maeda, A; Nakata, M; Shimizu, K; Yasuda, K; Yukawa, T | 1 |
Anzellotti, A; Awasthi, V; Bailey, J; Gali, H; Matlock, G; McFarland, A; Watson, J | 1 |
Mimae, T; Miyata, Y; Okada, M; Sasada, S; Tsubokawa, N; Yoshiya, T | 1 |
Guo, R; Jin, Y; Li, B; Xu, H | 1 |
Force, S | 1 |
De Raedt, N; De Ruysscher, D; Deroose, CM; Dooms, C; Gheysens, O; Nackaerts, K | 1 |
Bussink, J; de Geus-Oei, LF; Kaanders, JH; Looijen-Salamon, MG; Meijer, TW; Oyen, WJ; Schuurbiers, OC; Span, PN; van der Drift, MA; van der Heijden, EH; Visser, EP | 1 |
Choi, JY; Choi, YL; Han, J; Jeong, CJ; Jeong, JY; Lee, HY; Lee, KS | 1 |
Chen, X; Han, Y; Hu, X; Jiang, C; Tang, T; Yang, B; Zhao, H | 1 |
Koizumi, H; Kurimoto, N; Nakamura, H; Saji, H; Shinmyo, T; Tagaya, R; Takagi, M | 1 |
Khong, PL; Lee, EY; Lee, VH; Qian, W; Wong, MP; Yu, X | 1 |
Mimae, T; Mimura, T; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Tsutani, Y; Yoshimura, M | 1 |
Abe, M; Cong, Y; Kato, Y; Nomori, H; Sugimura, H | 1 |
Abiko, M; Sato, T; Shiono, S; Yanagawa, N | 1 |
Chou, PC; Ho, TY; Tsang, NM; Yang, CT; Yen, TC | 1 |
Boland Froemming, JM; Brinjikji, W; Holland, WP; Johnson, GB; Peikert, T | 1 |
Ito, H; Mimae, T; Mimura, T; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Yoshimura, M | 1 |
Ichimura, K; Kaji, M; Kanazawa, S; Mitsuhashi, T; Miyoshi, S; Sato, S; Shinya, T; Soh, J; Tanaka, T; Toyooka, S | 1 |
Cho, H; Choi, JY; Kim, HK; Kim, J; Lee, HY; Lee, KS; Um, SW | 1 |
Bae, KT; Goshima, S; Kanematsu, M; Kawada, H; Kawai, N; Noda, Y; Ono, H; Watanabe, H | 1 |
Bao, M; Chen, Q; Han, Y; Li, J; Li, Z; Lin, Q; Lin, Z; Liu, S; Peng, M; Xiong, L; Xu, B; Ye, B; Zhu, W | 1 |
Furukawa, T; Kushitani, K; Mimae, T; Miyata, Y; Okada, M; Takeshima, Y; Tsutani, Y | 1 |
Ahn, JH; Choi, JY; Choi, YS; Han, J; Kang, J; Kim, EY; Kim, HK; Kim, J; Kwon, OJ; Lee, G; Lee, HY; Lee, KS; Shim, YM; Song, SH | 1 |
Canpolat, T; Erhamamci, S; Nursal, GN; Reyhan, M; Yapar, AF | 1 |
Álvarez, A; Calzado, MA; Caro, T; Lara-Chica, M; Medina, M; Moreno, P; Muñoz, E; Salvatierra, Á; Soler-Torronteras, R | 1 |
Buvat, I; Chouahnia, K; Martinod, E; Orlhac, F; Soussan, M | 1 |
Aras, G; Bahadır, A; Çermik, TF; Gündoğan, C; Kanmaz, ZD; Kocatürk, C; Öz, B; Özkurt, CÜ; Tuncay, E; Yaşar, ZA | 1 |
Bi, GC; Fang, Y; Li, XM; Liang, Y; Liu, Y; Wu, N; Zhang, DS; Zhang, WJ; Zheng, R | 1 |
Gao, X; Wang, D; Yu, L; Zhang, M | 1 |
Fukuhara, M; Hasegawa, T; Higuchi, M; Inoue, T; Owada, Y; Suzuki, H; Watanabe, Y; Yamaura, T | 1 |
Higashi, K; Ishigaki, Y; Nakamura, Y; Oguchi, M; Sagawa, M; Shimasaki, M; Takegami, T; Tonami, H; Ueda, Y; Yamagishi, T | 1 |
Choi, JY; Choi, YS; Han, J; Jeong, JY; Jung, SH; Kim, HK; Kim, J; Kim, W; Lee, HY; Lee, KS; Shim, YM; Woo, MA; Zo, JI | 1 |
Ding, LY; Jiang, ZL; Liu, KJ; Wu, HY; Wu, SX | 1 |
Bae, JM; Choi, JY; Jeong, JY; Kim, HS; Kwon, OJ; Lee, HY; Lee, KS; Shim, YM; Sohn, I; Son, JY | 1 |
Annunziata, T; Bellafiore, S; Cesario, A; Filice, A; Fioroni, F; Formisano, D; Galeone, C; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T | 1 |
Matsuoka, K; Miyamoto, Y; Ueda, M | 1 |
Higashi, K; Ishigaki, Y; Nishida, H; Oguchi, M; Ohta, Y; Sakuma, T; Takegami, T; Tonami, H; Ueda, Y; Xu, K; Zhang, L | 1 |
Guo, J; Higashi, K; Ishigaki, Y; Nishida, H; Oguchi, M; Ohta, Y; Sakuma, T; Takegami, T; Tonami, H; Ueda, Y; Xu, K; Zhang, L | 1 |
Bugaj, JE; Gokhale, PC; Guleryuz, S; Manning, HC; Mantis, C; McKinley, ET; Wild, R; Zhao, P | 1 |
Matsumoto, I; Oda, M; Shimizu, Y; Tamura, M; Waseda, R; Watanabe, G | 1 |
Neuman, A; Ouvrier, MJ; Pop, G; Soussan, M; Weinmann, P | 1 |
Fukuda, I; Hatanaka, R; Kimura, D; Sakai, T; Tsushima, T; Yamada, Y | 1 |
Alavi, A; Codreanu, I; Torigian, DA; Zhuang, H | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Lung Adenocarcinoma
Article | Year |
---|---|
Perianal Paget
Topics: Adenocarcinoma of Lung; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Paget Disease, Extramammary; Positron Emission Tomography Computed Tomography | 2023 |
Use of high-resolution computed tomography and positron emission tomography/computed tomography in the management of stage IA adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
157 other study(ies) available for fluorodeoxyglucose f18 and Lung Adenocarcinoma
Article | Year |
---|---|
Commentary: A Guiding Light in the Night?: Maximum Standardized Uptake Value Associated With High-Risk Features in Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Treatment Outcome | 2022 |
Solitary Isolated Dural Metastasis From Lung Adenocarcinoma Mimicking Meningioma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Positron Emission Tomography Computed Tomography | 2022 |
Accuracy of
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prognosis; Retrospective Studies; United States | 2022 |
Prediction model based on 18F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Application of Simultaneous
Topics: Adenocarcinoma of Lung; Cell Proliferation; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Prospective Studies; Retrospective Studies | 2022 |
Editorial for "Application of Simultaneous 18F-FDG PET With Monoexponential, Biexponential, and Stretched Exponential Model-Based Diffusion-Weighted MR Imaging in Assessing the Proliferation Status of Lung Adenocarcinoma".
Topics: Adenocarcinoma of Lung; Cell Proliferation; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; ROC Curve | 2022 |
Absence of clinical benefit of FDG PET-CT in staging T1 part-solid lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; United Kingdom | 2022 |
Relationship between
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Young Adult | 2022 |
18F-fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Microenvironment | 2022 |
Parotid gland metastasis of lung adenocarcinoma identified on surveillance
Topics: Adenocarcinoma of Lung; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Parotid Gland; Parotid Neoplasms; Positron Emission Tomography Computed Tomography | 2022 |
Relationships between SUVmax of lung adenocarcinoma and different T stages, histological grades and pathological subtypes: a retrospective cohort study in China.
Topics: Adenocarcinoma of Lung; China; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Glycolysis; Humans; Imidazoles; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Multi-lesion radiomics of PET/CT for non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Carcinoembryonic Antigen; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
The Value of 18F-FDG PET/CT in the Diagnosis of Tuberculous Pleurisy and in the Differential Diagnosis between Tuberculous Pleurisy and Pleural Metastasis from Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pleura; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tuberculosis, Pleural | 2022 |
Combination of
Topics: Adenocarcinoma of Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Predictive Value of
Topics: Adenocarcinoma of Lung; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2023 |
Invasive area to tumor ratio is a significant prognostic factor for non-small cell lung cancer.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Retrospective Studies | 2022 |
Predictive value of intratumor metabolic and heterogeneity parameters on [
Topics: Adenocarcinoma of Lung; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Editorial for "Predictive Value of
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Complete Metabolic Response in Adenocarcinoma Lung With Lymphangitic Carcinomatosis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
18F-FDG and 18F-Fluciclovine Uptake in Poorly Differentiated Lung Adenocarcinoma in the Setting of Biochemically Recurrent Prostatic Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2022 |
Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Invasive mucinous adenocarcinoma of the lung: clinicopathological features,
Topics: Adenocarcinoma of Lung; Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
The Humeral Metastasis as the Initial Presentation of Lung Adenocarcinoma Revealed by 18F-FDG PET/CT.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Humerus; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
FDG PET/CT in a Case of Lung Adenocarcinoma With Diffuse Cavitary Intrapulmonary Metastases.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Predicting the pathological invasiveness of early lung adenocarcinoma prior to surgery using Deauville criteria: reliability and validity.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies | 2023 |
Machine learning approach using 18 F-FDG PET-based radiomics in differentiation of lung adenocarcinoma with bronchoalveolar distribution and infection.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Machine Learning; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2023 |
Prognostic Role of Biologically Active Volume of Disease in Patients With Metastatic Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
The value of preoperative positron emission tomography/computed tomography in differentiating the invasive degree of hypometabolic lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Applications of radiomics-based analysis pipeline for predicting epidermal growth factor receptor mutation status.
Topics: Adenocarcinoma of Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Correlation of
Topics: Adenocarcinoma of Lung; Biomarkers; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Tumor Microenvironment | 2023 |
Multivariate analysis based on the maximum standard unit value of
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pleura; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
The value on SUV-derived parameters assessed on
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Positron Emission Tomography Computed Tomography | 2023 |
Characteristics of fibrotic-foci-like lung adenocarcinoma on 18 F-FDG PET/computed tomography and HRCT.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Value of preoperative
Topics: Adenocarcinoma of Lung; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
FDG PET texture indices as imaging biomarkers for epidermal growth factor receptor mutation status in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Biomarkers; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Detection of the gene mutation of epidermal growth factor receptor in lung adenocarcinoma by radiomic features from a small amount of PET data.
Topics: Adenocarcinoma of Lung; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Bilateral Pulmonary Enteric Adenocarcinoma on FDG PET/CT.
Topics: Adenocarcinoma of Lung; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
The Utility of SUVmax as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aspartate-tRNA Ligase; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
A comparison of 18 F-FDG PET-based radiomics and deep learning in predicting regional lymph node metastasis in patients with resectable lung adenocarcinoma: a cross-scanner and temporal validation study.
Topics: Adenocarcinoma of Lung; Deep Learning; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Retrospective Studies | 2023 |
Correlation between maximum standardized uptake values on FDG-PET and microenvironmental factors in patients with clinical stage IA radiologic pure-solid lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiography; Stromal Cells; Tomography, X-Ray Computed; Tumor Microenvironment | 2019 |
Multiclonality and Radiosensitivity of Granulocyte-colony Stimulating Factor-Producing Lung Adenocarcinoma Positive for an Activating EGFR Mutation.
Topics: Adenocarcinoma of Lung; Clonal Evolution; ErbB Receptors; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiation Tolerance; Radiopharmaceuticals; Treatment Outcome | 2020 |
Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence.
Topics: Adenocarcinoma of Lung; Aged; Biological Transport; Carboxylic Acids; Cyclobutanes; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence | 2020 |
Prognostic value of 18F-FDG PET parameters in patients with locally advanced non-small cell lung cancer treated with induction chemotherapy.
Topics: Adenocarcinoma of Lung; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2020 |
Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically resected pulmonary adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aged; Area Under Curve; B7-H1 Antigen; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
SUVmax of
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tumor Burden | 2020 |
Enhanced glucose metabolism mediated by CD147 is associated with
Topics: Adenocarcinoma of Lung; Animals; Apoptosis; Basigin; Cell Differentiation; Cell Movement; Cell Proliferation; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
The effect of systemic inflammation indexes and
Topics: Adenocarcinoma of Lung; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphocytes; Male; Middle Aged; Monocytes; Positron-Emission Tomography; Prognosis; Retrospective Studies; Systemic Inflammatory Response Syndrome; Tumor Burden | 2020 |
Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth.
Topics: Adenocarcinoma of Lung; Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Gene Deletion; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 2; Humans; Male; Mice; Mice, Transgenic; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Positron-Emission Tomography; Spectrometry, Mass, Secondary Ion | 2020 |
Value of
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tuberculosis | 2021 |
Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [
Topics: Adenocarcinoma of Lung; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron Emission Tomography Computed Tomography; Retrospective Studies; Survival Rate; Treatment Outcome | 2021 |
Pulmonary Adenocarcinoma Metastasis to the Breast Unexpectedly Discovered on Re-staging
Topics: Adenocarcinoma of Lung; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mammography; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2021 |
Primary metabolic tumor volume from 18F-FDG PET/CT associated with epidermal growth factor receptor mutation in lung adenocarcinoma patients.
Topics: Adenocarcinoma of Lung; Adult; Aged; Biomarkers, Tumor; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Mutation; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2020 |
Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies | 2021 |
Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Chemotherapy, Adjuvant; Deep Learning; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Image Processing, Computer-Assisted; Immune Checkpoint Inhibitors; Lung; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Pneumonectomy; Positron-Emission Tomography; Progression-Free Survival; Retrospective Studies; RNA-Seq; Tumor Burden; Tumor Microenvironment | 2020 |
Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Patient Selection; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2021 |
Adenocarcinoma of the Lung With Initial Presentation as Painful Testicular Metastasis: 18F-FDG PET/CT Findings in an Unusual Case.
Topics: Adenocarcinoma of Lung; Cancer Pain; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Testicular Neoplasms | 2021 |
Machine learning based on clinico-biological features integrated
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Machine Learning; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
[Experience with High-grade Fetal Lung Adenocarcinoma;Report of a Case].
Topics: Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aged; ErbB Receptors; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Mutation; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Protein Kinase Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors | 2020 |
Lung Adenocarcinoma Presenting as a Soft Tissue Metastasis to the Shoulder: A Case Report.
Topics: Adenocarcinoma of Lung; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Sarcoma; Shoulder | 2021 |
The prediction of spread through air spaces with preoperative 18F-FDG PET/CT in cases with primary lung adenocarcinoma, its effect on the decision for an adjuvant treatment and its prognostic role.
Topics: Adenocarcinoma of Lung; Adult; Aged; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis | 2021 |
Prognostic role of standard uptake value according to pathologic features of lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2022 |
Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; ROC Curve; Transcription Initiation, Genetic | 2017 |
Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
A 33-Year-Old Woman With a Fluorodeoxyglucose-Avid Left Lower Lobe Mass.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Pulmonary Sclerosing Hemangioma; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cohort Studies; Deoxyglucose; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Hydroxybenzoates; Lung; Lung Neoplasms; Male; Mice; Mice, Nude; Middle Aged; Phenotype; Positron-Emission Tomography; Prognosis; Survival Analysis; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |
Supraclavicular schwannoma mimicking a lymphadenopathy in a lung cancer patient: PET/CT findings.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Clavicle; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphadenopathy; Male; Neurilemmoma; Positron Emission Tomography Computed Tomography | 2017 |
18F-FDG Uptake in Ischemic Colitis During Follow-up of a Patient With Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Colitis, Ischemic; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
Solitary Choroidal Metastasis From Lung Adenocarcinoma on FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Choroid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography | 2017 |
Serendipitous Discovery of Isolated Gastric Metastases From Adenocarcinoma of the Lung on Staging 18F-FDG PET-CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2017 |
CT and PET/CT fusion for lung cancer biopsy planning.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Spontaneous regression of FDG/PET positive lung adenocarcinoma in an elderly man.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Regression, Spontaneous; Neoplasm Staging | 2017 |
The maximum standardized uptake value of preoperative positron emission tomography/computed tomography in lung adenocarcinoma with a ground-glass opacity component of less than 30 mm.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies | 2018 |
68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Carcinoma, Renal Cell; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Oligopeptides; Positron Emission Tomography Computed Tomography | 2018 |
Dynamic Adaptation of Tumor Immune Response With Nivolumab Demonstrated by 18F-FDG PET/CT.
Topics: Adaptation, Physiological; Adenocarcinoma; Adenocarcinoma of Lung; Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Nivolumab; Positron Emission Tomography Computed Tomography | 2018 |
Comparison of different automated lesion delineation methods for metabolic tumor volume of 18F-FDG PET/CT in patients with stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome; Tumor Burden | 2017 |
CK7/CK20 Double-Negative Pulmonary Enteric Adenocarcinoma With Histopathological Evaluation of Transformation Zone Between Enteric Adenocarcinoma and Conventional Pulmonary Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy; Chemotherapy, Adjuvant; Colonic Neoplasms; Colonoscopy; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Keratin-20; Keratin-7; Lung; Lung Neoplasms; Male; Pneumonectomy; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Relation of EGFR Mutation Status to Metabolic Activity in Localized Lung Adenocarcinoma and Its Influence on the Use of FDG PET/CT Parameters in Prognosis.
Topics: Adenocarcinoma of Lung; Aged; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mutation; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2018 |
FDG-PET/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factors.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2018 |
Predictive value of dual-time
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2018 |
Topics: Adenocarcinoma of Lung; Aged; Aged, 80 and over; Cancer-Associated Fibroblasts; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Profiling; Glucose Transporter Type 1; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycolysis; Glycosylation; Hexosamines; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Survival Analysis; Tumor Microenvironment | 2018 |
Diagnosis of Multiple Primary Intestinal-Type Adenocarcinoma in the Lung by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography | 2018 |
[Pulmonary Enteric Adenocarcinoma;Report of a Case].
Topics: Adenocarcinoma of Lung; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Can Quantitative Volumetric Analysis Predict Tumor Recurrence in the Patients with Mucinous Adenocarcinoma of the Lung After Surgical Resection?
Topics: Adenocarcinoma of Lung; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2019 |
2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography | 2018 |
Primary Pulmonary Colloid Adenocarcinoma: How Can We Obtain a Precise Diagnosis?
Topics: Adenocarcinoma of Lung; Adenocarcinoma, Mucinous; Aged; Asymptomatic Diseases; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Prediction of Occult Lymph Node Metastasis Using Tumor-to-Blood Standardized Uptake Ratio and Metabolic Parameters in Clinical N0 Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2018 |
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Microvessels; Middle Aged; Necrosis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Concurrent Pancreatic Metastasis From Lung Adenocarcinoma and Primary Cholangiocarcinoma on FDG PET/CT Imaging.
Topics: Adenocarcinoma of Lung; Adult; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
18F-FDG PET/CT of Lung Adenocarcinoma With Ovarian Metastases.
Topics: Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Intratumoral heterogeneity as measured using the tumor-stroma ratio and PET texture analyses in females with lung adenocarcinomas differs from that of males with lung adenocarcinomas or squamous cell carcinomas.
Topics: Adenocarcinoma of Lung; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sex Factors | 2019 |
Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images.
Topics: Adenocarcinoma of Lung; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Organometallic Compounds; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2019 |
Combining fluorine-18 fluorodeoxyglucose positron emission tomography and pathological risk factors to predict postoperative recurrence in stage I lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prognosis; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors | 2019 |
Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2019 |
ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway.
Topics: Adenocarcinoma of Lung; ATPases Associated with Diverse Cellular Activities; Cell Movement; Cell Proliferation; Cells, Cultured; Chromones; DNA-Binding Proteins; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Lung Neoplasms; Male; Middle Aged; Morpholines; Proto-Oncogene Proteins c-akt | 2019 |
[Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies | 2019 |
Focal Immunotherapy-Induced Pancreatitis Mimicking Metastasis on FDG PET/CT.
Topics: Adenocarcinoma of Lung; Antibodies, Monoclonal, Humanized; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunotherapy; Male; Middle Aged; Pancreatitis; Positron Emission Tomography Computed Tomography | 2019 |
Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Propensity Score; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Vessels; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2014 |
A rare case of synchronous fetal type adenocarcinoma and mucinous adenocarcinoma of the lung evaluated by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenocarcinoma, Mucinous; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Multiple Pulmonary Nodules; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Histopathologic characterization of lung adenocarcinoma in relation to fluorine-18-fluorodeoxyglucose uptake on positron emission tomography.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2013 |
Synchronous metastatic pulmonary adenocarcinoma with small cell lymphoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography | 2014 |
Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Benzylidene Compounds; Cell Line, Tumor; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Inflammation Mediators; Ki-67 Antigen; Lung Neoplasms; Male; Mice; Mice, Nude; Multimodal Imaging; Phosphorylation; Piperidones; Positron-Emission Tomography; Signal Transduction; Time Factors; Tomography, X-Ray Computed; Transcription Factor RelA; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasms.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD34; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Dihydrouracil Dehydrogenase (NADP); Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Microvessels; Middle Aged; Neovascularization, Pathologic; Neuroendocrine Tumors; Orotate Phosphoribosyltransferase; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thymidylate Synthase; Thymus Neoplasms; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A; Young Adult | 2014 |
FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma in Situ; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
Lung cancer with sarcoid reaction in the lymph nodes following chemoradiotherapy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Cisplatin; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Irinotecan; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiation Dosage; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
A "dose on demand" Biomarker Generator for automated production of [(18)F]F(-) and [(18)F]FDG.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cyclotrons; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heterografts; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2014 |
Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
[Gene-targeted radiation therapy mediated by radiation-sensitive promoter in lung adenocarcinoma and the feasibility of micro-PET/CT in evaluation of therapeutic effectiveness in small animals].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Baculoviridae; Cell Line, Tumor; Combined Modality Therapy; Early Growth Response Protein 1; Fluorodeoxyglucose F18; Genetic Therapy; Genetic Vectors; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasm Transplantation; Peptide Fragments; Plasminogen; Platelet Endothelial Cell Adhesion Molecule-1; Positron-Emission Tomography; Promoter Regions, Genetic; Random Allocation; Recombinant Proteins; Tomography, X-Ray Computed; Tumor Burden; Vascular Endothelial Growth Factor A | 2014 |
Invited commentary.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Small lesion, severe consequences. An intriguing ventilation-perfusion scintigraphy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Perfusion Imaging; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Squamous Cell; Cell Hypoxia; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Monocarboxylic Acid Transporters; Muscle Proteins; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Symporters; Tumor Microenvironment | 2014 |
Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Anaplastic Lymphoma Kinase; Biomarkers, Tumor; Case-Control Studies; Female; Fluorodeoxyglucose F18; Gene Rearrangement; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Tomography, X-Ray Computed | 2015 |
Relative low glycometabolism may also occur in invasive lung adenocarcinoma with visceral pleural invasion: case report and comments.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Pleura; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Mutation; Neoplasm Staging; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
What are the radiologic findings predictive of indolent lung adenocarcinoma?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Diffusion-weighted magnetic resonance imaging in preoperative assessment of non-small cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Noninvasive Differential Diagnosis of Pulmonary Nodules Using the Standardized Uptake Value Index.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2015 |
Total lesion glycolysis determined per RECIST 1.1 criteria predicts survival in EGFR mutation-negative patients with advanced lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies | 2015 |
Unexpectedly fludeoxyglucose (18F) avid well-differentiated adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Pleura; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Brain Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Unnecessary Procedures | 2015 |
F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Vessels; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Regression Analysis; Retrospective Studies; ROC Curve; Survival Analysis; Tumor Burden | 2015 |
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed; Tomography, X-Ray Computed; Tumor Burden | 2016 |
A Case of a Man With Isolated Breast Metastasis From Lung Adenocarcinoma Incidentally Detected by FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Carcinoma, Squamous Cell; Cohort Studies; Dyrk Kinases; Female; Fluorodeoxyglucose F18; Gene Expression; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nuclear Proteins; Primary Cell Culture; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; RNA, Messenger; Ubiquitin-Protein Ligases | 2015 |
18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2015 |
Contribution of ¹⁸Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Base Sequence; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Mutation; Nuclear Proteins; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sequence Analysis, DNA; Thyroid Nuclear Factor 1; Transcription Factors | 2016 |
[Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sex Factors; Statistics, Nonparametric; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve | 2016 |
FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Monitoring, Physiologic; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Neutrophil Infiltration; Nivolumab; Pemetrexed; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Correlation of HIF-1α/HIF-2α expression with FDG uptake in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Basic Helix-Loop-Helix Transcription Factors; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged | 2016 |
Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed | 2017 |
Targeted therapy of multiple liver metastases after resected solitary gastric metastasis and primary pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2016 |
Pathologic stratification of operable lung adenocarcinoma using radiomics features extracted from dual energy CT images.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2017 |
18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Blood Glucose; Body Weight; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2017 |
Costal chondrosarcoma requiring differential diagnosis from metastatic tumor.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy; Bone Neoplasms; Chondrosarcoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Osteotomy; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Ribs; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Carbonic Anhydrase IX; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Postoperative Period; Prognosis; Recurrence; Retrospective Studies; Risk; Vascular Endothelial Growth Factor D | 2010 |
VEGF-A and its isoform VEGF₁₂₁ mRNA expression measured by quantitative real-time RT-PCR: correlation with F-18 FDG uptake and aggressiveness of lung adenocarcinoma: preliminary study.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A | 2011 |
18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Lung Neoplasms; Mice; Mice, Nude; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Pyrazines; Receptor, IGF Type 1; Receptor, Insulin; Xenograft Model Antitumor Assays | 2011 |
Radiologic and nuclear medicine predictors of tumor invasiveness in patients with clinical stage IA lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Reproducibility of Results; Retrospective Studies; Risk Assessment; ROC Curve; Survival Analysis; Tomography, X-Ray Computed | 2011 |
Diagnosis of synchronous isolated splenic metastasis from lung adenocarcinoma: complementary role of FDG PET/CT and diffusion-weighted MRI.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Diffusion; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Splenic Neoplasms; Tomography, X-Ray Computed | 2011 |
A clinical study of the prognostic factors for postoperative early recurrence in patients who underwent complete resection for pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymphocyte Count; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutrophils; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tumor Burden | 2011 |
Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Patellar metastasis from lung adenocarcinoma revealed by FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Patella; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Odds Ratio; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |